Search research articles
Contact Us
Filters
Showing results (221-230 of 328) with videos related to
Page
of 33
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 15, 2000
Dose-finding study of a once-daily indinavir/ritonavir regimen
P W Hugen, D M Burger, H J ter Hofstede, et al.
Clinical Pharmacokinetics
|
May 23, 2013
Pharmacokinetic-pharmacodynamic modeling of the antihypertensive effect of eprosartan in Black and White hypertensive patients
Petra C van Rijn-Bikker, Oliver Ackaert, Nelleke Snelder, et al.
Journal of Clinical Microbiology
|
March 20, 2015
Has CXCL13 an added value in diagnosis of neurosyphilis?
Khutso M Mothapo, Marcel M Verbeek, Lieven B van der Velden, et al.
Synapse (New York, N.Y.)
|
August 25, 1999
Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain
L Reneman, J Booij, J Lavalaye, et al.
Clinical and Diagnostic Laboratory Immunology
|
September 25, 1997
Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands
M M Herremans, A M van Loon, J H Reimerink, et al.
AIDS (London, England)
|
November 14, 1998
Pharmacokinetic interaction between the proton pump inhibitor omeprazole and the HIV protease inhibitor indinavir
D M Burger, P W Hugen, F P Kroon, et al.
Epidemiology and Infection
|
January 29, 2002
A comparison of gastroenteritis in a general practice-based study and a community-based study
M A de Wit, L M Kortbeek, M P Koopmans, et al.
Analytical Biochemistry
|
February 15, 1994
Monochlorobimane does not selectively label glutathione in peripheral blood mononuclear cells
A J van der Ven, P Mier, W H Peters, et al.
Acta Paediatrica (Oslo, Norway : 1992)
|
July 4, 2003
Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents
B M Frost, G Lönnerholm, P Koopmans, et al.
Pharmacy World & Science : PWS
|
July 26, 2002
Saquinavir soft-gel capsules (Fortovase) give lower exposure than expected, even after a high-fat breakfast
P W H Hugen, D M Burger, P P Koopmans, et al.
Page
of 33
Search research articles
Search
Showing results (221-230 of 328) with videos related to
Sort By:
Page
of 33
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 15, 2000
Dose-finding study of a once-daily indinavir/ritonavir regimen
P W Hugen, D M Burger, H J ter Hofstede, et al.
Clinical Pharmacokinetics
|
May 23, 2013
Pharmacokinetic-pharmacodynamic modeling of the antihypertensive effect of eprosartan in Black and White hypertensive patients
Petra C van Rijn-Bikker, Oliver Ackaert, Nelleke Snelder, et al.
Journal of Clinical Microbiology
|
March 20, 2015
Has CXCL13 an added value in diagnosis of neurosyphilis?
Khutso M Mothapo, Marcel M Verbeek, Lieven B van der Velden, et al.
Synapse (New York, N.Y.)
|
August 25, 1999
Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain
L Reneman, J Booij, J Lavalaye, et al.
Clinical and Diagnostic Laboratory Immunology
|
September 25, 1997
Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands
M M Herremans, A M van Loon, J H Reimerink, et al.
AIDS (London, England)
|
November 14, 1998
Pharmacokinetic interaction between the proton pump inhibitor omeprazole and the HIV protease inhibitor indinavir
D M Burger, P W Hugen, F P Kroon, et al.
Epidemiology and Infection
|
January 29, 2002
A comparison of gastroenteritis in a general practice-based study and a community-based study
M A de Wit, L M Kortbeek, M P Koopmans, et al.
Analytical Biochemistry
|
February 15, 1994
Monochlorobimane does not selectively label glutathione in peripheral blood mononuclear cells
A J van der Ven, P Mier, W H Peters, et al.
Acta Paediatrica (Oslo, Norway : 1992)
|
July 4, 2003
Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents
B M Frost, G Lönnerholm, P Koopmans, et al.
Pharmacy World & Science : PWS
|
July 26, 2002
Saquinavir soft-gel capsules (Fortovase) give lower exposure than expected, even after a high-fat breakfast
P W H Hugen, D M Burger, P P Koopmans, et al.
Page
of 33